title: [The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].
authors.affiliation: KYS:n sisätautien klinikka, Kuopio. esa.jantunen@kuh.fi
authors.forename: Esa
authors.initials: E
authors.lastname: Jantunen
authors.forename: Karri
authors.initials: K
authors.lastname: Penttilä
authors.forename: Taru
authors.initials: T
authors.lastname: Kuittinen
authors.forename: Tapio
authors.initials: T
authors.lastname: Nousiainen
mesh_terms: D000284:Administration, Oral; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005387:Finland; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D011446:Prospective Studies; D011799:Quinazolines / Q000627:therapeutic use*; D018570:Risk Assessment; D013922:Thrombocytosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D011799:Quinazolines; C021139:anagrelide